| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.453 | 19.301 | 20.282 | 18.773 | 2.665 | 1.571 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 22.464 | 19.301 | 20.282 | 18.773 | 2.665 | 1.571 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 9.938 | 9.842 | 12.724 | 12.928 | 16.153 | 3.252 | 6.194 | 2.884 | 946 | 756 |
| Gross Profit/Loss - EUR | 12.526 | 9.459 | 7.559 | 5.844 | -13.488 | -1.681 | -6.194 | -2.884 | -946 | -756 |
| Net Profit/Loss - EUR | 11.852 | 9.073 | 7.356 | 5.656 | -13.556 | -1.724 | -6.194 | -2.884 | -946 | -756 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medica - Popesti S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 130.458 | 138.185 | 58.589 | 63.109 | 48.330 | 50.554 | 43.252 | 40.490 | 39.422 | 28.586 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 125.156 | 130.342 | 52.856 | 37.276 | 39.219 | 34.827 | 34.055 | 34.161 | 34.057 | 28.586 |
| Cash | 5.302 | 7.842 | 5.733 | 25.833 | 9.111 | 15.727 | 9.197 | 6.330 | 5.365 | 0 |
| Shareholders Funds | 129.605 | 137.356 | 57.710 | 62.307 | 47.164 | 50.501 | 43.188 | 40.438 | 39.370 | 28.525 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 853 | 828 | 879 | 802 | 1.166 | 53 | 65 | 52 | 52 | 62 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Medica - Popesti S.r.l.